GEA pharma separator garners interest from Europe and Asia

1 min read

GEA’s kytero single-use pharma separator has created interest and orders from research institutes and companies in the pharmaceutical industry from Europe, Asia and Europe, following its launch in autumn 2021.

GEA has introduced its kytero single use pharma separator, for single-use biopharmaceutical processing.
GEA has introduced its kytero single use pharma separator, for single-use biopharmaceutical processing. - Image: GEA

GEA's kytero offers maximum separation efficiency with gentle product handling and creates new ways for processing cell culture-based fermentations with a yield of 98% and more. This technology is in high demand for pilot plants, university laboratories, and small-scale production by biopharmaceutical manufacturers worldwide, as it relies on the well-established technology of disc separators, so reducing the use of filtration technology. The kytero 500 was developed for a capacity of up to 150 l/h and so it is suitable for laboratories and small batches. In terms of scale-up, another model will follow in the short term.

GEA initiated the development of kytero at the request of the biopharmaceutical industry. The basis for the development work was the experience of around 130 years in mechanical separation technology and GEA's well-established stainless-steel pharmaceutical disc separators. (Disk Stack). GEA experts succeeded in developing a single-use separator for the biopharmaceutical industry that offers the same high-quality performance as the stainless-steel separators commonly used to date. The GEA feed system guarantees particularly gentle product treatment, and the vitality of shear-sensitive products is preserved. Product runs and scientific tests at the ZHAW School of Engineering in Zurich have confirmed this.